Included in the formulation
АТХ:V.03.A.X Other medications
Pharmacodynamics:Contains glycyrrhizic acid, licurazide, mucous substances, flavonoids. Glycyrrhizic acid has an anti-inflammatory effect, flavone glycoside-liquidoritide and 2,4,4-tri-oxycalcon have an antispasmodic effect.
The drug has expectorant and moderate anti-inflammatory effect.
Pharmacokinetics:
Not studied.
Indications:As part of complex therapy used for treatment Infectious-inflammatory diseases of the respiratory tract.
X.J00-J06.J04 Acute laryngitis and tracheitis
X.J10-J18.J15 Bacterial pneumonia, not elsewhere classified
X.J20-J22.J20 Acute bronchitis
X.J30-J39.J37 Chronic laryngitis and laryngotracheitis
Contraindications:Diabetes mellitus, hypokalemia, individual intolerance.
Carefully:
Bronchial asthma.
Pregnancy and lactation:Recommendations for FDA - Category B. It is used for physiologically occurring pregnancy and during lactation.
Dosing and Administration:Children
1-12 years: from ½ teaspoon to 1 dessert spoon 3-5 times / day.
Adults
1 tablespoon 3-5 times a day.
The highest single dose: 1 tablespoon.
The highest daily dose: 5 tablespoons.
Side effects:With prolonged use, it is possible to develop peripheral edema.
Allergic reactions.
Overdose:Cases of overdose not described.
Interaction:Hypokalemia with simultaneous use with cardiac glycosides, antiarrhythmics (quinidine).
Special instructions:With long-term use, it is possible to develop violations of the electrolyte balance, functional disorders of cardiac activity.